Evidence map›Paper›PMID 30813227›Full record

ArticleInternational journal of molecular sciences2019

Inducible Loss of the Aryl Hydrocarbon Receptor Activates Perigonadal White Fat Respiration and Brown Fat Thermogenesis via Fibroblast Growth Factor 21.

Nathaniel G Girer, Dwayne Carter, Nisha Bhattarai, Mehnaz Mustafa, Larry Denner, Craig Porter, Cornelis J Elferink

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Skeletal Toxicity of Coplanar Polychlorinated Biphenyl Congener 126 in the Rat Is Aryl Hydrocarbon Receptor Dependent.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nathaniel G GirerDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. ngirer89@gmail.com.
Dwayne CarterDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. dwaynecarter1981@gmail.com.
Nisha BhattaraiDivision of Surgical Sciences, Department of Surgery, UTMB & Metabolism Unit, Shriners Hospitals for Children, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. nibhatta@utmb.edu.
Mehnaz MustafaDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. mehnazmustafa.mehnaz3@gmail.com.
Larry DennerDepartment of Internal Medicine, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. ladenner@utmb.edu.
Craig PorterDivision of Surgical Sciences, Department of Surgery, UTMB & Metabolism Unit, Shriners Hospitals for Children, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. cr2porte@utmb.edu.
Cornelis J ElferinkDepartment of Pharmacology and Toxicology, The University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA. coelferi@utmb.edu.
The University of Texas Medical Branch at Galveston · USShriners Hospitals for Children - Galveston · US

Funding

Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
UTMB Clinical and Translational Science AwardKL2TR001441 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AMEREDES, BILL T · 2015 to 2024
$4.0M
Aryl Hydrocarbon Receptor-Mediated Epigenetic ProcessesR01ES026874 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 2016 to 2020
$2.2M
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of ActionR01ES033682 · NIEHS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Casey W Wright · 2022 to 2026
$1.8M
Mechanistic Insights into Aryl Hydrocarbon Receptor Regulation of Fibroblast Growth Factor 21 and its Influence on Systemic Energy MetabolismF32DK116489 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GIRER, NATHANIEL · 2019 to 2019
$61k
RADIATION-INDUCED DNA DAMAGE AND REPAIR IN EUKARYOTESK04CA001441 · NCI · EMORY UNIVERSITY · PI DOETSCH, PAUL W. · 1989 to 1993
–
NCATS NIH HHS KL2TR001441NIDDK NIH HHS F32 DK116489NIEHS NIH HHS P30 ES030285NIEHS NIH HHS R01 ES026874NIEHS NIH HHS R01 ES033682NIEHS NIH HHS T32ES007254NIH HHS P30ES006676NIH HHS R01ES026874
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor highly expressed in hepatocytes. Researchers have employed global and liver-specific conditional

Indexed as

Cell RespirationThermogenesisAdipose Tissue, BrownAdipose Tissue, WhiteAdiposityAnimalsBody WeightDiet, High-FatDrinkingEnergy MetabolismFeeding BehaviorFemaleFibroblast Growth FactorsGonadsHepatocytesLipid Dropletsfibroblast growth factor 21Fibroblast Growth FactorsReceptors, Aryl HydrocarbonTamoxifenaryl hydrocarbon receptorfibroblast growth factor 21uncoupling protein 1

Identifiers

PMID30813227
PMCPMC6412252
OpenAlexW2917565635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.